Special article
Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing
Reforma de la evaluación económica de medicamentos en España: propuestas del Comité Asesor para la Financiación de la Prestación Farmacéutica
Marta Trapero-Bertrana,b,h,
, Jaume Puig-Junoyc,h, Emilio J. Alegre-del-Reyd,h, Ana Clopése,h, Félix Lobof,h, Ana Ortegag,h
a Department of Economics and Business, University of Lleida, Lleida, Spain
b Biomedical Research Institute of Lleida, Lleida, Spain
c Pompeu Fabra University, Barcelona School of Management, Barcelona, Spain
d Pharmacy Service, Hospital Universitario Puerto Real, Cádiz, Spain
e Medications Area, Catalan Health Service, Barcelona, Spain
f Department of Economics, Carlos III University, Funcas, Madrid, Spain
g Pharmacy Service, Clínica Universidad de Navarra, Pamplona, Spain
h Advisory Committee on the Financing of Pharmaceutical (CAPF), Spain
Read
4647
Timeswas read the article
1393
Total PDF
3254
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 307 | 50 | 357 |
| 2025 9 | 340 | 62 | 402 |
| 2025 8 | 314 | 108 | 422 |
| 2025 7 | 197 | 91 | 288 |
| 2025 6 | 396 | 341 | 737 |
| 2025 5 | 275 | 71 | 346 |
| 2025 4 | 270 | 77 | 347 |
| 2025 3 | 250 | 87 | 337 |
| 2025 2 | 562 | 284 | 846 |
| 2025 1 | 343 | 222 | 565 |
